Clinical Trials Directory

Trials / Sponsors / Longbio Pharma

Longbio Pharma

Industry · 13 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
Complement-mediated Renal Diseases
Phase 22026-02-02
Not Yet RecruitingA Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With N
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Phase 22026-01-20
Not Yet RecruitingEfficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuri
Paroxysmal Nocturnal Hemoglobinuria
Phase 22025-12-05
Active Not RecruitingA Study of Single Dose of LP-003 in Adolescent Subjects
Allergic Diseases
Phase 1 / Phase 22025-10-01
RecruitingEfficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Allergic Asthma
Phase 22025-01-25
Active Not RecruitingEfficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
PNH - Paroxysmal Nocturnal Hemoglobinuria
Phase 22024-11-14
Active Not RecruitingA Study of Single Dose of LP-003 in Healthy Adult Subjects
Chronic Spontaneous Urticaria
Phase 12024-10-23
Active Not RecruitingEfficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Phase 32024-08-01
CompletedEfficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
Chronic Spontaneous Urticaria
Phase 22024-01-26
CompletedA Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 12023-11-23
CompletedEfficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult
Seasonal Allergic Rhinitis
Phase 22023-07-06
CompletedA Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
Myelodysplastic Syndrome (MDS)
Phase 12022-09-03
CompletedA Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
Chronic Spontaneous Urticaria
Phase 12022-07-13